Verseau Therapeutics

Last updated: April 17, 2024

George Golumbeski, Chairman
George Golumbeski, Chairman
Country: USA | Funding: $54.3M (+)

Website: https://www.verseautx.com/

Verseau is the Macrophage Company Transforming Immunotherapy